This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

3 Aug 2011

KKR Buys Pfizer’s Capsugel for US$2.4B

Capsugel will maintain a corporate presence in the US. All Pfizer employees currently dedicated to this business will be transferred to Capsugel.

New York-based private equity group Kohlberg Kravis Roberts (KKR) has bought Pfizer’s Capsugel business for US$2.4bn, following approval by the US and EU regulatory authorities. Capsugel generated about $750m in revenue last year.


Capsugel is the world’s leading provider of hard capsules and an innovator in drug delivery systems for the pharmaceutical, OTC and health and nutrition industries. The firm offers a range of products and services, from hard gelatin, vegetarian and liquid-filled capsules, to innovative r&d equipment and liquid formulations as part of its Licaps drug delivery system.


The firm will maintain a corporate presence in the US, with its global headquarters located in New Jersey. All Pfizer employees currently dedic

Related News